Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance
This paper assesses the potential impact of antimicrobial resistance on global economic growth and poverty. The analysis uses a global computable general equilibrium model and a microsimulation framework that together capture impact channels relate...
Main Authors: | , , , , , |
---|---|
Format: | Working Paper |
Language: | English English |
Published: |
World Bank, Washington, DC
2017
|
Subjects: | |
Online Access: | http://documents.worldbank.org/curated/en/190151498872848485/Assessing-the-global-economic-and-poverty-effects-of-antimicrobial-resistance http://hdl.handle.net/10986/27636 |
id |
okr-10986-27636 |
---|---|
recordtype |
oai_dc |
spelling |
okr-10986-276362021-06-14T10:12:16Z Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance Ahmed, Syud Amer Baris, Enis Go, Delfin S. Lofgren, Hans Osorio-Rodarte, Israel Thierfelder, Karen PANDEMICS HEALTH POVERTY MEASUREMENT GENERAL EQUILIBRIUM MODEL This paper assesses the potential impact of antimicrobial resistance on global economic growth and poverty. The analysis uses a global computable general equilibrium model and a microsimulation framework that together capture impact channels related to health, mortality, labor productivity, health care financing, and production in the livestock and other sectors. The effects spread across countries via trade flows that may be affected by new trade restrictions. Relative to a world without antimicrobial resistance, the losses during 2015–50 may sum to $85 trillion in gross domestic product and $23 trillion in global trade (in present value). By 2050, the cost in global gross domestic product could range from 1.1 percent (low case) to 3.8 percent (high case). Antimicrobial resistance is expected to make it more difficult to eliminate extreme poverty. Under the high antimicrobial resistance scenario, by 2030, an additional 24.1 million people would be extremely poor, of whom 18.7 million live in low-income countries. In general, developing countries will be hurt the most, especially those with the lowest incomes. 2017-07-19T16:18:12Z 2017-07-19T16:18:12Z 2017-06 Working Paper http://documents.worldbank.org/curated/en/190151498872848485/Assessing-the-global-economic-and-poverty-effects-of-antimicrobial-resistance http://hdl.handle.net/10986/27636 English en Policy Research Working Paper;No. 8133 CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Publications & Research Publications & Research :: Policy Research Working Paper |
repository_type |
Digital Repository |
institution_category |
Foreign Institution |
institution |
Digital Repositories |
building |
World Bank Open Knowledge Repository |
collection |
World Bank |
language |
English English |
topic |
PANDEMICS HEALTH POVERTY MEASUREMENT GENERAL EQUILIBRIUM MODEL |
spellingShingle |
PANDEMICS HEALTH POVERTY MEASUREMENT GENERAL EQUILIBRIUM MODEL Ahmed, Syud Amer Baris, Enis Go, Delfin S. Lofgren, Hans Osorio-Rodarte, Israel Thierfelder, Karen Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance |
relation |
Policy Research Working Paper;No. 8133 |
description |
This paper assesses the potential impact
of antimicrobial resistance on global economic growth and
poverty. The analysis uses a global computable general
equilibrium model and a microsimulation framework that
together capture impact channels related to health,
mortality, labor productivity, health care financing, and
production in the livestock and other sectors. The effects
spread across countries via trade flows that may be affected
by new trade restrictions. Relative to a world without
antimicrobial resistance, the losses during 2015–50 may sum
to $85 trillion in gross domestic product and $23 trillion
in global trade (in present value). By 2050, the cost in
global gross domestic product could range from 1.1 percent
(low case) to 3.8 percent (high case). Antimicrobial
resistance is expected to make it more difficult to
eliminate extreme poverty. Under the high antimicrobial
resistance scenario, by 2030, an additional 24.1 million
people would be extremely poor, of whom 18.7 million live in
low-income countries. In general, developing countries will
be hurt the most, especially those with the lowest incomes. |
format |
Working Paper |
author |
Ahmed, Syud Amer Baris, Enis Go, Delfin S. Lofgren, Hans Osorio-Rodarte, Israel Thierfelder, Karen |
author_facet |
Ahmed, Syud Amer Baris, Enis Go, Delfin S. Lofgren, Hans Osorio-Rodarte, Israel Thierfelder, Karen |
author_sort |
Ahmed, Syud Amer |
title |
Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance |
title_short |
Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance |
title_full |
Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance |
title_fullStr |
Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance |
title_full_unstemmed |
Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance |
title_sort |
assessing the global economic and poverty effects of antimicrobial resistance |
publisher |
World Bank, Washington, DC |
publishDate |
2017 |
url |
http://documents.worldbank.org/curated/en/190151498872848485/Assessing-the-global-economic-and-poverty-effects-of-antimicrobial-resistance http://hdl.handle.net/10986/27636 |
_version_ |
1764465609039413248 |